 | • レポートコード：GIR201106414 • 出版社/出版日：GlobalInfoResearch / 2020年10月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、131ページ • 納品方法：Eメール • 産業分類：医薬品・医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本書では、パーキンソン病（PD）治療薬の世界市場を調査対象にし、パーキンソン病（PD）治療薬の市場概要、メーカー情報、メーカー別販売量・売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（ドーパミンアゴニスト、モノアミンオキシダーゼ阻害剤、アセチルコリンエステラーゼ阻害剤、グルタミン酸阻害剤）、用途別分析（病院、家庭用、療養所、その他）、市場予測（2021年～2025年）、販売チャンネル・代理店分析情報などを整理しました。 ・市場概要 ・メーカー情報：Boehringer Ingelheim、Biogen、Teva Pharmaceutical Industries、GlaxoSmithKline、Addex Therapeutics、Novartis、Eli Lilly、Abital Pharma、AbbVie、Eisai、Otsuka Pharmaceutical、F. Hoffmann-La Roche、Pfizer、Kyowa Hakko Kirin、H. Lundbeck、Impax Laboratories ・メーカー別販売量、売上、市場シェア ・パーキンソン病（PD）治療薬の地域別市場分析 ・パーキンソン病（PD）治療薬の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・パーキンソン病（PD）治療薬のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・パーキンソン病（PD）治療薬のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・パーキンソン病（PD）治療薬の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・パーキンソン病（PD）治療薬の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・パーキンソン病（PD）治療薬の種類別市場規模2015-2020：ドーパミンアゴニスト、モノアミンオキシダーゼ阻害剤、アセチルコリンエステラーゼ阻害剤、グルタミン酸阻害剤 ・パーキンソン病（PD）治療薬の用途別市場規模2015-2020：病院、家庭用、療養所、その他 ・パーキンソン病（PD）治療薬の世界市場予測2021-2025：地域別、種類別、用途別 ・販売チャンネル・代理店分析 ・調査の結果・結論 |
Market Overview
The global Parkinson’s Disease (PD) Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Parkinson’s Disease (PD) Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Parkinson’s Disease (PD) Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Parkinson’s Disease (PD) Drugs market has been segmented into
Dopamine Agonist
Monoamine Oxidase Inhibitors
Acetylcholinesterase Inhibitors
Glutamate Inhibitors
By Application, Parkinson’s Disease (PD) Drugs has been segmented into:
Hospital
Family
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Parkinson’s Disease (PD) Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Parkinson’s Disease (PD) Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Parkinson’s Disease (PD) Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Parkinson’s Disease (PD) Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Parkinson’s Disease (PD) Drugs Market Share Analysis
Parkinson’s Disease (PD) Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Parkinson’s Disease (PD) Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Parkinson’s Disease (PD) Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Parkinson’s Disease (PD) Drugs are:
Boehringer Ingelheim
Biogen
Teva Pharmaceutical Industries
GlaxoSmithKline
Addex Therapeutics
Novartis
Eli Lilly
Abital Pharma
AbbVie
Eisai
Otsuka Pharmaceutical
F. Hoffmann-La Roche
Pfizer
Kyowa Hakko Kirin
H. Lundbeck
Impax Laboratories
Among other players domestic and global, Parkinson’s Disease (PD) Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Parkinson’s Disease (PD) Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Parkinson’s Disease (PD) Drugs, with price, sales, revenue and global market share of Parkinson’s Disease (PD) Drugs in 2018 and 2019.
Chapter 3, the Parkinson’s Disease (PD) Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Parkinson’s Disease (PD) Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Parkinson’s Disease (PD) Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Parkinson’s Disease (PD) Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Parkinson’s Disease (PD) Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Parkinson’s Disease (PD) Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Dopamine Agonist
1.2.3 Monoamine Oxidase Inhibitors
1.2.4 Acetylcholinesterase Inhibitors
1.2.5 Glutamate Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Parkinson’s Disease (PD) Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Family
1.4 Overview of Global Parkinson’s Disease (PD) Drugs Market
1.4.1 Global Parkinson’s Disease (PD) Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer Ingelheim SWOT Analysis
2.1.4 Boehringer Ingelheim Product and Services
2.1.5 Boehringer Ingelheim Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Biogen
2.2.1 Biogen Details
2.2.2 Biogen Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Biogen SWOT Analysis
2.2.4 Biogen Product and Services
2.2.5 Biogen Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva Pharmaceutical Industries
2.3.1 Teva Pharmaceutical Industries Details
2.3.2 Teva Pharmaceutical Industries Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva Pharmaceutical Industries SWOT Analysis
2.3.4 Teva Pharmaceutical Industries Product and Services
2.3.5 Teva Pharmaceutical Industries Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 GlaxoSmithKline SWOT Analysis
2.4.4 GlaxoSmithKline Product and Services
2.4.5 GlaxoSmithKline Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Addex Therapeutics
2.5.1 Addex Therapeutics Details
2.5.2 Addex Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Addex Therapeutics SWOT Analysis
2.5.4 Addex Therapeutics Product and Services
2.5.5 Addex Therapeutics Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Eli Lilly
2.7.1 Eli Lilly Details
2.7.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Eli Lilly SWOT Analysis
2.7.4 Eli Lilly Product and Services
2.7.5 Eli Lilly Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Abital Pharma
2.8.1 Abital Pharma Details
2.8.2 Abital Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Abital Pharma SWOT Analysis
2.8.4 Abital Pharma Product and Services
2.8.5 Abital Pharma Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 AbbVie
2.9.1 AbbVie Details
2.9.2 AbbVie Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 AbbVie SWOT Analysis
2.9.4 AbbVie Product and Services
2.9.5 AbbVie Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Eisai
2.10.1 Eisai Details
2.10.2 Eisai Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Eisai SWOT Analysis
2.10.4 Eisai Product and Services
2.10.5 Eisai Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Otsuka Pharmaceutical
2.11.1 Otsuka Pharmaceutical Details
2.11.2 Otsuka Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Otsuka Pharmaceutical SWOT Analysis
2.11.4 Otsuka Pharmaceutical Product and Services
2.11.5 Otsuka Pharmaceutical Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 F. Hoffmann-La Roche
2.12.1 F. Hoffmann-La Roche Details
2.12.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 F. Hoffmann-La Roche SWOT Analysis
2.12.4 F. Hoffmann-La Roche Product and Services
2.12.5 F. Hoffmann-La Roche Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Pfizer
2.13.1 Pfizer Details
2.13.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Pfizer SWOT Analysis
2.13.4 Pfizer Product and Services
2.13.5 Pfizer Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Kyowa Hakko Kirin
2.14.1 Kyowa Hakko Kirin Details
2.14.2 Kyowa Hakko Kirin Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Kyowa Hakko Kirin SWOT Analysis
2.14.4 Kyowa Hakko Kirin Product and Services
2.14.5 Kyowa Hakko Kirin Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 H. Lundbeck
2.15.1 H. Lundbeck Details
2.15.2 H. Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 H. Lundbeck SWOT Analysis
2.15.4 H. Lundbeck Product and Services
2.15.5 H. Lundbeck Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.16 Impax Laboratories
2.16.1 Impax Laboratories Details
2.16.2 Impax Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Impax Laboratories SWOT Analysis
2.16.4 Impax Laboratories Product and Services
2.16.5 Impax Laboratories Parkinson’s Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Parkinson’s Disease (PD) Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Parkinson’s Disease (PD) Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Parkinson’s Disease (PD) Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Parkinson’s Disease (PD) Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Parkinson’s Disease (PD) Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Parkinson’s Disease (PD) Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Parkinson’s Disease (PD) Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
4.5 South America Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Parkinson’s Disease (PD) Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Parkinson’s Disease (PD) Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Parkinson’s Disease (PD) Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Parkinson’s Disease (PD) Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Parkinson’s Disease (PD) Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Parkinson’s Disease (PD) Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
6.3 UK Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
6.4 France Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Parkinson’s Disease (PD) Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Parkinson’s Disease (PD) Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Parkinson’s Disease (PD) Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
7.5 India Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Parkinson’s Disease (PD) Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Parkinson’s Disease (PD) Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Parkinson’s Disease (PD) Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Parkinson’s Disease (PD) Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Parkinson’s Disease (PD) Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Parkinson’s Disease (PD) Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Parkinson’s Disease (PD) Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Parkinson’s Disease (PD) Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Parkinson’s Disease (PD) Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Parkinson’s Disease (PD) Drugs Price by Type (2015-2020)
11 Global Parkinson’s Disease (PD) Drugs Market Segment by Application
11.1 Global Parkinson’s Disease (PD) Drugs Sales Market Share by Application (2015-2020)
11.2 Global Parkinson’s Disease (PD) Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Parkinson’s Disease (PD) Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Parkinson’s Disease (PD) Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Parkinson’s Disease (PD) Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Parkinson’s Disease (PD) Drugs Market Forecast (2021-2025)
12.2.2 Europe Parkinson’s Disease (PD) Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Parkinson’s Disease (PD) Drugs Market Forecast (2021-2025)
12.2.4 South America Parkinson’s Disease (PD) Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Parkinson’s Disease (PD) Drugs Market Forecast (2021-2025)
12.3 Parkinson’s Disease (PD) Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Parkinson’s Disease (PD) Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Parkinson’s Disease (PD) Drugs Market Share Forecast by Type (2021-2025)
12.4 Parkinson’s Disease (PD) Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Parkinson’s Disease (PD) Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Parkinson’s Disease (PD) Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Parkinson's Disease (PD) Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Parkinson's Disease (PD) Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Parkinson's Disease (PD) Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Major Business
Table 9. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 10. Boehringer Ingelheim SWOT Analysis
Table 11. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Product and Services
Table 12. Boehringer Ingelheim Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Biogen Basic Information, Manufacturing Base and Competitors
Table 14. Biogen Parkinson's Disease (PD) Drugs Major Business
Table 15. Biogen Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 16. Biogen SWOT Analysis
Table 17. Biogen Parkinson's Disease (PD) Drugs Product and Services
Table 18. Biogen Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Teva Pharmaceutical Industries Basic Information, Manufacturing Base and Competitors
Table 20. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Major Business
Table 21. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 22. Teva Pharmaceutical Industries SWOT Analysis
Table 23. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Product and Services
Table 24. Teva Pharmaceutical Industries Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 26. GlaxoSmithKline Parkinson's Disease (PD) Drugs Major Business
Table 27. GlaxoSmithKline Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 28. GlaxoSmithKline SWOT Analysis
Table 29. GlaxoSmithKline Parkinson's Disease (PD) Drugs Product and Services
Table 30. GlaxoSmithKline Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Addex Therapeutics Basic Information, Manufacturing Base and Competitors
Table 32. Addex Therapeutics Parkinson's Disease (PD) Drugs Major Business
Table 33. Addex Therapeutics Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 34. Addex Therapeutics SWOT Analysis
Table 35. Addex Therapeutics Parkinson's Disease (PD) Drugs Product and Services
Table 36. Addex Therapeutics Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Parkinson's Disease (PD) Drugs Major Business
Table 39. Novartis Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Parkinson's Disease (PD) Drugs Product and Services
Table 42. Novartis Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 44. Eli Lilly Parkinson's Disease (PD) Drugs Major Business
Table 45. Eli Lilly Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 46. Eli Lilly SWOT Analysis
Table 47. Eli Lilly Parkinson's Disease (PD) Drugs Product and Services
Table 48. Eli Lilly Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Abital Pharma Basic Information, Manufacturing Base and Competitors
Table 50. Abital Pharma Parkinson's Disease (PD) Drugs Major Business
Table 51. Abital Pharma Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 52. Abital Pharma SWOT Analysis
Table 53. Abital Pharma Parkinson's Disease (PD) Drugs Product and Services
Table 54. Abital Pharma Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. AbbVie Basic Information, Manufacturing Base and Competitors
Table 56. AbbVie Parkinson's Disease (PD) Drugs Major Business
Table 57. AbbVie Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 58. AbbVie SWOT Analysis
Table 59. AbbVie Parkinson's Disease (PD) Drugs Product and Services
Table 60. AbbVie Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Eisai Basic Information, Manufacturing Base and Competitors
Table 62. Eisai Parkinson's Disease (PD) Drugs Major Business
Table 63. Eisai Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 64. Eisai SWOT Analysis
Table 65. Eisai Parkinson's Disease (PD) Drugs Product and Services
Table 66. Eisai Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. Otsuka Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 68. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Major Business
Table 69. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 70. Otsuka Pharmaceutical SWOT Analysis
Table 71. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Product and Services
Table 72. Otsuka Pharmaceutical Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 74. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Major Business
Table 75. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 76. F. Hoffmann-La Roche SWOT Analysis
Table 77. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Product and Services
Table 78. F. Hoffmann-La Roche Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Pfizer Basic Information, Manufacturing Base and Competitors
Table 80. Pfizer Parkinson's Disease (PD) Drugs Major Business
Table 81. Pfizer Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 82. Pfizer SWOT Analysis
Table 83. Pfizer Parkinson's Disease (PD) Drugs Product and Services
Table 84. Pfizer Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Kyowa Hakko Kirin Basic Information, Manufacturing Base and Competitors
Table 86. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Major Business
Table 87. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 88. Kyowa Hakko Kirin SWOT Analysis
Table 89. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Product and Services
Table 90. Kyowa Hakko Kirin Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. H. Lundbeck Basic Information, Manufacturing Base and Competitors
Table 92. H. Lundbeck Parkinson's Disease (PD) Drugs Major Business
Table 93. H. Lundbeck Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 94. H. Lundbeck SWOT Analysis
Table 95. H. Lundbeck Parkinson's Disease (PD) Drugs Product and Services
Table 96. H. Lundbeck Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Impax Laboratories Basic Information, Manufacturing Base and Competitors
Table 98. Impax Laboratories Parkinson's Disease (PD) Drugs Major Business
Table 99. Impax Laboratories Parkinson's Disease (PD) Drugs Total Revenue (USD Million) (2018-2019)
Table 100. Impax Laboratories SWOT Analysis
Table 101. Impax Laboratories Parkinson's Disease (PD) Drugs Product and Services
Table 102. Impax Laboratories Parkinson's Disease (PD) Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 103. Global Parkinson's Disease (PD) Drugs Sales by Manufacturer (2018-2019) (K Pcs)
Table 104. Global Parkinson's Disease (PD) Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 105. Global Parkinson's Disease (PD) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 106. Global Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2015-2020)
Table 107. Global Parkinson's Disease (PD) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 108. North America Parkinson's Disease (PD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 109. North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2015-2020)
Table 110. North America Parkinson's Disease (PD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 111. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2015-2020)
Table 112. Europe Parkinson's Disease (PD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 113. Europe Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2015-2020)
Table 114. Europe Parkinson's Disease (PD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 115. Asia-Pacific Parkinson's Disease (PD) Drugs Sales by Regions (2015-2020) (K Pcs)
Table 116. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Regions (2015-2020)
Table 117. Asia-Pacific Parkinson's Disease (PD) Drugs Revenue by Regions (2015-2020) (USD Million)
Table 118. South America Parkinson's Disease (PD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 119. South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2015-2020)
Table 120. South America Parkinson's Disease (PD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 121. South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2015-2020)
Table 122. Middle East & Africa Parkinson's Disease (PD) Drugs Sales by Countries (2015-2020) (K Pcs)
Table 123. Middle East & Africa Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2015-2020)
Table 124. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue by Countries (2015-2020) (USD Million)
Table 125. Middle East & Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2015-2020)
Table 126. Global Parkinson's Disease (PD) Drugs Sales by Type (2015-2020) (K Pcs)
Table 127. Global Parkinson's Disease (PD) Drugs Sales Share by Type (2015-2020)
Table 128. Global Parkinson's Disease (PD) Drugs Revenue by Type (2015-2020) (USD Million)
Table 129. Global Parkinson's Disease (PD) Drugs Revenue Share by Type (2015-2020)
Table 130. Global Parkinson's Disease (PD) Drugs Sales by Application (2015-2020) (K Pcs)
Table 131. Global Parkinson's Disease (PD) Drugs Sales Share by Application (2015-2020)
Table 132. Global Parkinson's Disease (PD) Drugs Sales Forecast by Regions (2021-2025) (K Pcs)
Table 133. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Regions (2021-2025)
Table 134. Global Parkinson's Disease (PD) Drugs Sales Forecast by Type (2021-2025) (K Pcs)
Table 135. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Type (2021-2025)
Table 136. Global Parkinson's Disease (PD) Drugs Sales Forecast by Application (2021-2025)
Table 137. Global Parkinson's Disease (PD) Drugs Market Share Forecast by Application (2021-2025)
Table 138. Direct Channel Pros & Cons
Table 139. Indirect Channel Pros & Cons
Table 140. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Parkinson's Disease (PD) Drugs Picture
Figure 2. Global Sales Market Share of Parkinson's Disease (PD) Drugs by Type in 2019
Figure 3. Dopamine Agonist Picture
Figure 4. Monoamine Oxidase Inhibitors Picture
Figure 5. Acetylcholinesterase Inhibitors Picture
Figure 6. Glutamate Inhibitors Picture
Figure 7. Parkinson's Disease (PD) Drugs Sales Market Share by Application in 2018
Figure 8. Hospital Picture
Figure 9. Family Picture
Figure 10. Global Parkinson's Disease (PD) Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Parkinson's Disease (PD) Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Parkinson's Disease (PD) Drugs Sales Market Share by Manufacturer in 2019
Figure 31. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Parkinson's Disease (PD) Drugs Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 36. Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions (2015-2020)
Figure 38. Global Parkinson's Disease (PD) Drugs Revenue Market Share by Regions in 2018
Figure 39. North America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020)
Figure 40. Europe Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020)
Figure 42. South America Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020)
Figure 44. North America Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries (2015-2020)
Figure 46. North America Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2018
Figure 47. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2018
Figure 49. United States Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Canada Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Mexico Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Europe Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2019
Figure 55. Germany Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. UK Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. France Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Asia-Pacific Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Parkinson's Disease (PD) Drugs Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Parkinson's Disease (PD) Drugs Revenue Market Share by Regions 2019
Figure 63. China Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Korea Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. India Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Southeast Asia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. South America Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2019
Figure 70. South America Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2019
Figure 71. Brazil Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Argentina Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Parkinson's Disease (PD) Drugs Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Parkinson's Disease (PD) Drugs Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Egypt Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Turkey Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. South Africa Parkinson's Disease (PD) Drugs Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Global Parkinson's Disease (PD) Drugs Sales and Growth Rate (2021-2025) (K Pcs)
Figure 82. Global Parkinson's Disease (PD) Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Parkinson's Disease (PD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 84. Europe Sales Parkinson's Disease (PD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 85. Asia-Pacific Sales Parkinson's Disease (PD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 86. South America Sales Parkinson's Disease (PD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 87. Middle East & Africa Sales Parkinson's Disease (PD) Drugs Market Forecast (2021-2025) (K Pcs)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
メニエール病治療薬の世界市場 2020年 Market Overview The global Meniere Disease Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Meniere Disease Drugs m…- ゴナドトロピン放出ホルモン作動薬の世界市場 2020年 Market Overview The global Gonadotropin-releasing Hormone Agonist Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The …
- 乳がん治療薬の世界市場 2020年 Market Overview The global Breast Cancer Treatment Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Breast Cancer T…
- PD-L1阻害剤の世界市場 2020年 Market Overview The PD-L1 Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 代謝薬の世界市場 2020年 Market Overview The Metabolism Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…